These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12965246

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
    Tan Y, Williams EA, Lancia AJ, Zahm DS.
    Brain Res; 2000 Jun 30; 869(1-2):56-68. PubMed ID: 10865059
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G, Bérubé-Carrière N, Mendez JA, Leo D, Riad M, Descarries L, Lévesque D, Trudeau LE.
    Neuroscience; 2008 Sep 22; 156(1):59-70. PubMed ID: 18706980
    [Abstract] [Full Text] [Related]

  • 5. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM, Gash DM.
    Brain Res; 1995 Feb 20; 672(1-2):104-11. PubMed ID: 7749731
    [Abstract] [Full Text] [Related]

  • 6. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC, Zbarsky V, Datla KP, Croucher MJ, Dexter DT.
    J Neurochem; 2007 Nov 20; 103(3):1075-91. PubMed ID: 17714448
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle.
    Ferraz AC, Matheussi F, Szawka RE, Rizelio V, Delattre AM, Rigon P, Hermel Edo E, Xavier LL, Achaval M, Anselmo-Franci JA.
    Neurochem Res; 2008 Jul 20; 33(7):1238-46. PubMed ID: 18259859
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 20; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y.
    Brain Res; 2001 Jun 15; 904(1):67-75. PubMed ID: 11516412
    [Abstract] [Full Text] [Related]

  • 10. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.
    J Pharm Pharmacol; 2004 May 15; 56(5):649-54. PubMed ID: 15142343
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO.
    Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466
    [Abstract] [Full Text] [Related]

  • 14. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C, Fuxe K, Chadi G.
    J Neural Transm Suppl; 2009 Jan 23; (73):185-202. PubMed ID: 20411778
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
    Chen L, Zhang QJ, Liu J, Wang S, Ali U, Gui ZH, Wang Y.
    Brain Res; 2009 Aug 25; 1286():192-200. PubMed ID: 19545547
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
    Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P.
    Brain Res; 2000 Mar 24; 859(2):286-92. PubMed ID: 10719076
    [Abstract] [Full Text] [Related]

  • 20. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
    Knyihár-Csillik E, Chadaide Z, Mihály A, Krisztin-Péva B, Fenyo R, Vécsei L.
    Acta Neuropathol; 2006 Aug 24; 112(2):127-37. PubMed ID: 16788821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.